NCT06997029 2026-03-16
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Bristol-Myers Squibb
Phase 1 Recruiting
Bristol-Myers Squibb
Merck Sharp & Dohme LLC
AstraZeneca
Dartmouth-Hitchcock Medical Center
Carrick Therapeutics Limited